SNF Platform Study of HR+/ HER2-advanced Breast Cancer

Clinical trial NCT05594095 · RECRUITING

Trial details

NCT number: NCT05594095
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasm Breast Cancer Hormone Receptor Positive Tumor HER2-negative Breast Cancer Advanced Breast Cancer

Start date: 2022-12-30
Primary completion: 2025-12-01
Enrollment: 620

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.